A detailed history of T. Rowe Price Investment Management, Inc. transactions in Insmed Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,277,143 shares of INSM stock, worth $168 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,277,143
Previous 2,435,962 6.52%
Holding current value
$168 Million
Previous $163 Million 1.85%
% of portfolio
0.1%
Previous 0.1%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $9.85 Million - $12.5 Million
-158,819 Reduced 6.52%
2,277,143 $166 Million
Q2 2024

Aug 14, 2024

SELL
$22.0 - $69.71 $22.3 Million - $70.8 Million
-1,015,618 Reduced 29.42%
2,435,962 $163 Million
Q1 2024

May 15, 2024

SELL
$25.72 - $29.94 $61.7 Million - $71.8 Million
-2,399,026 Reduced 41.0%
3,451,580 $93.6 Million
Q4 2023

Feb 14, 2024

SELL
$23.42 - $31.74 $57.9 Million - $78.5 Million
-2,474,278 Reduced 29.72%
5,850,606 $181 Million
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $408,520 - $553,950
20,570 Added 0.25%
8,324,884 $210 Million
Q2 2023

Aug 14, 2023

SELL
$16.44 - $21.1 $1.83 Million - $2.34 Million
-111,116 Reduced 1.32%
8,304,314 $175 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $662,676 - $885,606
40,755 Added 0.49%
8,415,430 $143 Million
Q4 2022

Feb 14, 2023

BUY
$16.98 - $23.15 $5.23 Million - $7.13 Million
307,913 Added 3.82%
8,374,675 $167 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $168 Million - $228 Million
8,066,762 New
8,066,762 $174 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.